Morgan Stanley’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $13.5M | Sell |
|
|||||
|
2024
Q1 | $21.7M | Sell |
|
|||||
|
2023
Q4 | $64.1M | Buy |
|
|||||
|
2023
Q3 | $1.83M | Sell |
|
|||||
|
2023
Q2 | $5.11M | Sell |
|
|||||
|
2023
Q1 | $5.38M | Sell |
|
|||||
|
2022
Q4 | $17.4M | Buy |
|
|||||
|
2022
Q3 | $14.2M | Buy |
|
|||||
|
2022
Q2 | $10.2M | Buy |
|
|||||
|
2022
Q1 | $3.7M | Buy |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $768K | Buy |
|
|||||
|
2021
Q2 | $397K | Buy |
|
|||||
|
2021
Q1 | $73K | Sell |
|
|||||
|
2020
Q4 | $238K | Buy |
|